BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saadati R, Dadashzadeh S. Marked effects of combined TPGS and PVA emulsifiers in the fabrication of etoposide-loaded PLGA-PEG nanoparticles: in vitro and in vivo evaluation. Int J Pharm 2014;464:135-44. [PMID: 24451238 DOI: 10.1016/j.ijpharm.2014.01.014] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Song JG, Noh H, Lee SH, Han H. Lipid/Clay-Based Solid Dispersion Formulation for Improving the Oral Bioavailability of Curcumin. Pharmaceutics 2022;14:2269. [DOI: 10.3390/pharmaceutics14112269] [Reference Citation Analysis]
2 Haider T, Pandey V, Behera C, Kumar P, Gupta PN, Soni V. Nisin and nisin-loaded nanoparticles: a cytotoxicity investigation. Drug Dev Ind Pharm 2022;:1-42. [PMID: 35938875 DOI: 10.1080/03639045.2022.2111438] [Reference Citation Analysis]
3 Sheffey VV, Siew EB, Tanner EEL, Eniola-Adefeso O. PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery. Adv Healthc Mater 2022;11:e2101536. [PMID: 35032406 DOI: 10.1002/adhm.202101536] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Kumbhar PS, Nadaf S, Manjappa AS, Jha NK, Shinde SS, Chopade SS, Shete AS, Disouza JI, Sambamoorthy U, Kumar SA. D-ɑ-tocopheryl polyethylene glycol succinate: A review of multifarious applications in nanomedicines. OpenNano 2022;6:100036. [DOI: 10.1016/j.onano.2022.100036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Farooq MA, Xinyu H, Jabeen A, Ahsan A, Seidu TA, Kutoka PT, Wang B. Enhanced cellular uptake and cytotoxicity of vorinostat through encapsulation in TPGS-modified liposomes. Colloids Surf B Biointerfaces 2021;199:111523. [PMID: 33360624 DOI: 10.1016/j.colsurfb.2020.111523] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
6 Esim O, Bakirhan NK, Sarper M, Savaser A, Ozkan SA, Ozkan Y. Influence of emulsifiers on the formation and in vitro anticancer activity of epirubicin loaded PLGA nanoparticles. Journal of Drug Delivery Science and Technology 2020;60:102027. [DOI: 10.1016/j.jddst.2020.102027] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
7 Mó I, Sabino IJ, Melo-Diogo D, Lima-Sousa R, Alves CG, Correia IJ. The importance of spheroids in analyzing nanomedicine efficacy. Nanomedicine (Lond) 2020;15:1513-25. [PMID: 32552537 DOI: 10.2217/nnm-2020-0054] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
8 Animasawun RK, Taresco V, Swainson SME, Suksiriworapong J, Walker DA, Garnett MC. Screening and Matching Polymers with Drugs to Improve Drug Incorporation and Retention in Nanoparticles. Mol Pharm 2020;17:2083-98. [PMID: 32348676 DOI: 10.1021/acs.molpharmaceut.0c00236] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 Huang HL, Lin WJ. Dual Peptide-Modified Nanoparticles Improve Combination Chemotherapy of Etoposide and siPIK3CA Against Drug-Resistant Small Cell Lung Carcinoma. Pharmaceutics 2020;12:E254. [PMID: 32178266 DOI: 10.3390/pharmaceutics12030254] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
10 Akhlaghi S, Rabbani S, Alavi S, Alinaghi A, Radfar F, Dadashzadeh S, Haeri A. Green formulation of curcumin loaded lipid-based nanoparticles as a novel carrier for inhibition of post-angioplasty restenosis. Materials Science and Engineering: C 2019;105:110037. [DOI: 10.1016/j.msec.2019.110037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
11 Fan F, Tan D, Shang S, Wu X, Zhao J, Ran G, Lu X. Poly(3-hydroxybutyrate- co -3-hydroxyhexanoate) Biopolyester Based Nanoparticles as NVP-BEZ235 Delivery Vehicle for Tumor Targeting Therapy. Biomacromolecules 2019;20:3313-23. [DOI: 10.1021/acs.biomac.9b00505] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Guo D, Li Q, Sun Y, Guo J, Zhao Q, Yin X, Wei H, Wu S, Bi H. Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis. Nanotechnology 2019;30:165702. [PMID: 30641491 DOI: 10.1088/1361-6528/aafe36] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
13 Fan F, Wu X, Zhao J, Ran G, Shang S, Li M, Lu X. A Specific Drug Delivery System for Targeted Accumulation and Tissue Penetration in Prostate Tumors Based on Microbially Synthesized PHBHHx Biopolyester and iRGD Peptide Fused PhaP. ACS Appl Bio Mater 2018;1:2041-53. [DOI: 10.1021/acsabm.8b00524] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
14 Zhang M, He J, Zhang W, Liu J. Fabrication of TPGS-Stabilized Liposome-PLGA Hybrid Nanoparticle Via a New Modified Nanoprecipitation Approach: In Vitro and In Vivo Evaluation. Pharm Res 2018;35. [DOI: 10.1007/s11095-018-2485-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
15 Wright L, Rao S, Thomas N, Boulos RA, Prestidge CA. Ramizol® encapsulation into extended release PLGA micro- and nanoparticle systems for subcutaneous and intramuscular administration: in vitro and in vivo evaluation. Drug Dev Ind Pharm 2018;44:1451-7. [PMID: 29619851 DOI: 10.1080/03639045.2018.1459676] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
16 Fan F, Wang L, Ouyang Z, Wen Y, Lu X. Development and optimization of a tumor targeting system based on microbial synthesized PHA biopolymers and PhaP mediated functional modification. Appl Microbiol Biotechnol 2018;102:3229-41. [PMID: 29497797 DOI: 10.1007/s00253-018-8790-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
17 Chebil A, Léonard M, Six J, Nouvel C, Durand A. Nanoparticulate delivery systems for alkyl gallates: Influence of the elaboration process on particle characteristics, drug encapsulation and in-vitro release. Colloids and Surfaces B: Biointerfaces 2018;162:351-61. [DOI: 10.1016/j.colsurfb.2017.11.050] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
18 Khutoryanskiy VV. Beyond PEGylation: Alternative surface-modification of nanoparticles with mucus-inert biomaterials. Adv Drug Deliv Rev 2018;124:140-9. [PMID: 28736302 DOI: 10.1016/j.addr.2017.07.015] [Cited by in Crossref: 95] [Cited by in F6Publishing: 100] [Article Influence: 19.0] [Reference Citation Analysis]
19 Tsend-ayush A, Zhu X, Ding Y, Yao J, Yin L, Zhou J, Yao J. Lactobionic acid-conjugated TPGS nanoparticles for enhancing therapeutic efficacy of etoposide against hepatocellular carcinoma. Nanotechnology 2017;28:195602. [DOI: 10.1088/1361-6528/aa66ba] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
20 Radwan MA, AlQuadeib BT, Šiller L, Wright MC, Horrocks B. Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats. Drug Deliv 2017;24:40-50. [PMID: 28155565 DOI: 10.1080/10717544.2016.1228715] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 8.8] [Reference Citation Analysis]
21 Gaonkar RH, Ganguly S, Dewanjee S, Sinha S, Gupta A, Ganguly S, Chattopadhyay D, Chatterjee Debnath M. Garcinol loaded vitamin E TPGS emulsified PLGA nanoparticles: preparation, physicochemical characterization, in vitro and in vivo studies. Sci Rep 2017;7:530. [PMID: 28373669 DOI: 10.1038/s41598-017-00696-6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 9.0] [Reference Citation Analysis]
22 Li X, Li J, Luo J, Li K, Gao Q, Li J. A Novel Eco-friendly Blood Meal-based Bio-adhesive: Preparation and Performance. J Polym Environ 2018;26:607-15. [DOI: 10.1007/s10924-017-0976-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
23 Sahin A, Esendagli G, Yerlikaya F, Caban-toktas S, Yoyen-ermis D, Horzum U, Aktas Y, Khan M, Couvreur P, Capan Y. A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles’ characteristics and efficacy of intracellular delivery. Artificial Cells, Nanomedicine, and Biotechnology 2017;45:1657-64. [DOI: 10.1080/21691401.2016.1276924] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 6.7] [Reference Citation Analysis]
24 Lakkireddy HR, Bazile D. Building the design, translation and development principles of polymeric nanomedicines using the case of clinically advanced poly(lactide(glycolide))-poly(ethylene glycol) nanotechnology as a model: An industrial viewpoint. Adv Drug Deliv Rev 2016;107:289-332. [PMID: 27593265 DOI: 10.1016/j.addr.2016.08.012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
25 Cheng X, Yan H, Jia X, Zhang Z. Preparation and in vivo/in vitro evaluation of formononetin phospholipid/vitamin E TPGS micelles. J Drug Target 2016;24:161-8. [PMID: 26325229 DOI: 10.3109/1061186X.2015.1064435] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
26 Liu C, Yao S, Li X, Wang F, Jiang Y. iRGD-mediated core-shell nanoparticles loading carmustine and O6-benzylguanine for glioma therapy. J Drug Target 2017;25:235-46. [PMID: 27646474 DOI: 10.1080/1061186X.2016.1238091] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
27 Li J, Cheng X, Chen Y, He W, Ni L, Xiong P, Wei M. Vitamin E TPGS modified liposomes enhance cellular uptake and targeted delivery of luteolin: An in vivo/in vitro evaluation. International Journal of Pharmaceutics 2016;512:262-72. [DOI: 10.1016/j.ijpharm.2016.08.037] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 6.4] [Reference Citation Analysis]
28 Pereira ED, Cerruti R, Fernandes E, Peña L, Saez V, Pinto JC, Ramón JA, Oliveira GE, Souza Júnior FGD. Influence of PLGA and PLGA-PEG on the dissolution profile of oxaliplatin. Polímeros 2016;26:137-43. [DOI: 10.1590/0104-1428.2323] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
29 Zhu R, Wang Q, Zhu Y, Wang Z, Zhang H, Wu B, Wu X, Wang S. pH sensitive nano layered double hydroxides reduce the hematotoxicity and enhance the anticancer efficacy of etoposide on non-small cell lung cancer. Acta Biomater 2016;29:320-32. [PMID: 26485164 DOI: 10.1016/j.actbio.2015.10.029] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 6.3] [Reference Citation Analysis]
30 Yeo D, Wiraja C, Chuah YJ, Gao Y, Xu C. A Nanoparticle-based Sensor Platform for Cell Tracking and Status/Function Assessment. Sci Rep 2015;5:14768. [PMID: 26440504 DOI: 10.1038/srep14768] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
31 Braithwaite MC, Choonara YE, Kumar P, Tomar LK, Du Toit LC, Pillay V. A novel bile salts-lipase polymeric film-infused minitablet system for enhanced oral delivery of cholecalciferol. Pharm Dev Technol 2016;21:832-46. [PMID: 26333524 DOI: 10.3109/10837450.2015.1069329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
32 Liu H, Gao M, Xu H, Guan X, Lv L, Deng S, Zhang C, Tian Y. A Promising Emodin-Loaded Poly (Lactic-Co-Glycolic Acid)-d-α-Tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles for Liver Cancer Therapy. Pharm Res 2016;33:217-36. [PMID: 26334502 DOI: 10.1007/s11095-015-1781-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
33 Al-Quadeib BT, Radwan MA, Siller L, Horrocks B, Wright MC. Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization. Saudi Pharm J 2015;23:290-302. [PMID: 26106277 DOI: 10.1016/j.jsps.2014.11.004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 5.7] [Reference Citation Analysis]
34 Hong C, Dang Y, Lin G, Yao Y, Li G, Ji G, Shen H, Xie Y. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation. Int J Pharm 2014;477:251-60. [PMID: 25445518 DOI: 10.1016/j.ijpharm.2014.10.044] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 7.0] [Reference Citation Analysis]
35 Bu H, He X, Zhang Z, Yin Q, Yu H, Li Y. A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer. International Journal of Pharmaceutics 2014;471:206-13. [DOI: 10.1016/j.ijpharm.2014.05.039] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 6.6] [Reference Citation Analysis]